Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock

Journal of Intensive Care Medicine

Volumn 22, Issue 6, 2007, Pages 363-373

  Rivers, Emanuel P ^a,c   McCord, James ^b   Otero, Ronny ^a   Jacobsen, Gordon ^b   Loomba, Manisha ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

B type natriuretic peptide; Critical illness; Global tissue hypoxia; Myocardial dysfunction; Organ dysfunction; Sepsis; Septic shock; Severe sepsis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEART FAILURE; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SEX RATIO; STATISTICAL SIGNIFICANCE;

AGED; ANALYSIS OF VARIANCE; APACHE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOASSAY; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SEPSIS; SHOCK, SEPTIC;

EID: 36249007981     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066607307523     Document Type: Article

References (65)

1. Maisel A. B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clin. 2001 ; 19: 557-571.
2. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000 ; 355: 1126-1130.
3. Phua J., Lim TK, Lee KH B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med. 2005 ; 33: 2094-2013.
4. Hoffmann U., Brueckmann M., Bertsch T., et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab. 2005 ; 51: 373-379.
5. Cuthbertson BH, Patel RR, Croal BL, Barclay J., Hillis GS B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia. 2005 ; 60: 16-21.
6. Charpentier J., Luyt CE, Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004 ; 32: 660-665.
7. Tung RH, Garcia C., Morss AM, et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med. 2004 ; 32: 1643-1647.
8. Berendes E., Van Aken H., Raufhake C., Schmidt C., Assmann G., Walter M. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg. 2001 ; 93: 676-682.
9. McLean AS, Huang SJ The applications of B-type natriuretic peptide measurement in the intensive care unit. Curr Opin Crit Care. 2005 ; 11: 406-412.
10. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 ; 345: 1368-1377.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE APACHE II: a severity of disease classification system. Crit Care Med. 1985 ; 13: 818-829.
12. Le Gall JR, Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study [published correction appears in JAMA. 1994;271:1321]. JAMA. 1993 ; 270: 2957-2963.
13. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995 ; 23: 1638-1652.
14. Aduen J., Bernstein WK, Khastgir T., et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA. 1994 ; 272: 1678-1685.
15. Varpula M., Tallgren M., Saukkonen K., Voipio-Pulkki LM, Pettila V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005 ; 31: 1066-1071.
16. Silance PG, Vincent JL Oxygen extraction in patients with sepsis and heart failure: another look at clinical studies. Clin Intensive Care. 1994 ; 5: 4-14.
17. Kasnitz P., Druger GL, Yorra F., Simmons DH Mixed venous oxygen tension and hyperlactatemia: survival in severe cardiopulmonary disease. JAMA. 1976 ; 236: 570-574.
18. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981 ; 9: 591-597.
19. Maisel AS, Krishnaswamy P., Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002 ; 347: 161-167.
20. McCullough PA, Nowak RM, McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002 ; 106: 416-422.
21. Estenssoro E., Gonzalez F., Laffaire E., et al. Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU. Chest. 2005 ; 127: 598-603.
22. Brun-Buisson C., Doyon F., Carlet J., et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA. 1995 ; 274: 968-974.
23. Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005 ; 33: 2194-2201.
24. Parrillo JE Cardiovascular dysfunction in septic shock: new insights into a deadly disease. Int J Cardiol. 1985 ; 7: 314-321.
25. Parrillo JE, Burch C., Shelhamer JH, Parker MM, Natanson C., Schuette W. A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 1985 ; 76: 1539-1553.
26. Astiz ME, Rackow EC, Kaufman B., Falk JL, Weil MH Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med. 1988 ; 16: 655-658.
27. Karimova A., Pinsky DJ The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med. 2001 ; 27: 19-31.
28. Astiz ME, Rackow EC, Weil MH Oxygen delivery and utilization during rapidly fatal septic shock in rats. Circ Shock. 1986 ; 20: 281-290.
29. Fink MP Bench-to-bedside review: cytopathic hypoxia. Crit Care. 2002 ; 6: 491-499.
30. de Denus S., Pharand C., Williamson DR Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. Chest. 2004 ; 125: 652-668.
31. Mitaka C., Hirata Y., Nagura T., Tsunoda Y., Itoh M., Amaha K. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care. 1997 ; 12: 66-71.
32. Vieillard-Baron A., Schmitt JM, Augarde R., et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med. 2001 ; 29: 1551-1555.
33. Sibbald WJ, Paterson NA, Holliday RL, Anderson RA, Lobb TR, Duff JH Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest. 1978 ; 73: 583-591.
34. Astiz ME, Rackow EC, Falk JL, Kaufman BS, Weil MH Oxygen delivery and consumption in patients with hyper-dynamic septic shock. Crit Care Med. 1987 ; 15: 26-28.
35. Hopkins WE, Chen Z., Fukagawa NK, Hall C., Knot HJ, LeWinter MM Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation. 2004 ; 109: 2872-2877.
36. Zhang Y., Oliver JR, Horowitz JD The role of endothelin in mediating ischemia/hypoxia-induced atrial natriuretic peptide release. J Cardiovasc Pharmacol. 2004 ; 43: 227-233.
37. Nakanishi K., Tajima F., Itoh H., et al. Changes in atrial natriuretic peptide and brain natriuretic peptide associated with hypobaric hypoxia-induced pulmonary hypertension in rats. Virchows Arch. 2001 ; 439: 808-817.
38. Sun JZ, Chen SJ, Li G., Chen YF Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice. Am J Physiol Lung Cell Mol Physiol. 2000 ; 279: L511 - L519.
39. Goetze JP, Gore A., Moller CH, Steinbruchel DA, Rehfeld JF, Nielsen LB Acute myocardial hypoxia increases BNP gene expression. Faseb J. 2004 ; 18: 1928-1930.
40. Padilla F., Garcia-Dorado D., Agullo L., et al. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res. 2001 ; 51: 592-600.
41. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young JB, Mann DL Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996 ; 27: 1201-1206.
42. Witthaut R., Busch C., Fraunberger P., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003 ; 29: 1696-1702.
43. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998 ; 31: 391-398.
44. Ueland T., Kjekshus J., Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005 ; 46: 2018-2021.
45. He Q., LaPointe MC Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension. 1999 ; 33: 283-289.
46. MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 1997 ; 79: 1128-1131.
47. Tomaru Ki K., Arai M., Yokoyama T., et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 2002 ; 34: 649-659.
48. McLean AS, Huang SJ, Nalos M., Tang B., Stewart DE The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med. 2003 ; 31: 2611-2618.
49. Ueda R., Yokouchi M., Suzuki T., Otomo E., Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med. 2003 ; 114: 266-270.
50. Alboni P., Brignole M., Menozzi C., Scarfo S. Is sinus bradycardia a factor facilitating overt heart failure? Eur Heart J. 1999 ; 20: 252-255.
51. Thomas JT, Kelly RF, Thomas SJ, et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med. 2002 ; 112: 437-445.
52. Jefic D., Lee JW, Jefic D., Savoy-Moore RT, Rosman HS Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest. 2005 ; 128: 288-295.
53. Ander DS, Jaggi M., Rivers E., et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol. 1998 ; 82: 888-891.
54. Trzeciak S., Dellinger RP, Abate NL, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest. 2006 ; 129: 225-232.
55. Brueckmann M., Huhle G., Lang S., et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005 ; 112: 527-534.
56. Roch A., Allardet-Servent J., Michelet P., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med. 2005 ; 33: 1001-1007.
57. Hollenberg SM, Ahrens TS, Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004 ; 32: 1928 -1948.
58. Mendoza A., Kim YN, Chernoff A. Hypoglycemia in hospitalized adult patients without diabetes. Endocr Pract. 2005 ; 11: 91-96.
59. Fischer KF, Lees JA, Newman JH Hypoglycemia in hospitalized patients: causes and outcomes. N Engl J Med. 1986 ; 315: 1245-1250.
60. Shilo S., Berezovsky S., Friedlander Y., Sonnenblick M. Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc. 1998 ; 46: 978-982.
61. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am. 1989 ; 18: 103-121.
62. McCullough PA, Sandberg KR B-type natriuretic peptide and renal disease. Heart Fail Rev. 2003 ; 8: 355-358.
63. Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001 ; 7: 21-29.
64. Squara P., Bennett D., Perret C. Pulmonary artery catheter: does the problem lie in the users? Chest. 2002 ; 121: 2009-2015.
65. Mehta RL, Pascual MT, Soroko S., Chertow GM Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002 ; 288: 2547-2553.